Dark
Light
System
Institutional Investment Manager
EVENTIDE ASSET MANAGEMENT, LLC
EVENTIDE ASSET MANAGEMENT, LLC (CIK: 0001442891) incorporated in Delaware, located at One International Place, Boston, MA. Institutional holdings reported to the SEC.

Institutional Holdings (2016Q2)
Portfolio Summary: 129 holdings with a total value of $1,634,136,000.
#
Name
Shares
Value ($)
%
Options
Notes
1 RMR GROUP INC 37 1,000 0.00%
2 TERRAFORM GLOBAL INC 8,700 28,000 0.00%
3 TERRAFORM PWR INC CL A COM 4,650 51,000 0.00%
4 NATIONAL INSTRS CORP 2,800 77,000 0.00%
5 TESLA INC SR CV NT 0.25 19 100,000 89,000 0.01% PRN
6 WESTPAC BKG CORP 5,500 121,000 0.01%
7 VENTAS INC 1,700 124,000 0.01%
8 POWERSHARES BUILD AMERICA BOND PORTFOLIO ETF 4,211 133,000 0.01%
9 LXP INDUSTRIAL TRUST COM 14,500 147,000 0.01%
10 BUNGE LIMITED 3,400 201,000 0.01%
11 AMERIGAS PARTNERS L P 4,500 210,000 0.01%
12 NORFOLK SOUTHERN CORP 3,000 255,000 0.02%
13 WELLTOWER INC 3,600 274,000 0.02%
14 TELEFONAKTIEBOLAGET LM ERICS 36,000 276,000 0.02%
15 LIBERTY PROP 7,300 290,000 0.02%
16 ABB LTD 15,500 307,000 0.02%
17 BLACKROCK TAX MUNICPAL BD TR SHS 13,450 328,000 0.02%
18 EATON CORP PLC 5,800 346,000 0.02%
19 NRG YIELD INC 33,000 514,000 0.03%
20 COLUMBIA PIPELINE PARTNERS LP 35,500 533,000 0.03%
21 BRANDYWINE RLTY TR 34,500 580,000 0.04%
22 BROOKFIELD RENEWABLE PARTNER 20,000 596,000 0.04%
23 JOHNSON CTLS INTL PLC 15,200 673,000 0.04%
24 TAIWAN SEMICONDUCTOR MFG LTD 25,800 677,000 0.04%
25 HERCULES CAPITAL INC 64,000 795,000 0.05%
26 SPECTRA ENERGY PARTNERS LP 17,200 811,000 0.05%
27 DICERNA PHARMACEUTICALS INC 377,000 1,131,000 0.07%
28 ZOSANO PHARMA CORP 888,300 1,173,000 0.07%
29 IMMUNE DESIGN CORP 180,000 1,469,000 0.09%
30 CYTOMX THERAPEUTICS INC COM 150,000 1,532,000 0.09%
31 ACCURAY INCORPORATED COM 306,200 1,589,000 0.10%
32 TANDEM DIABETES CARE INC COM 275,000 2,074,000 0.13%
33 Tracon Pharmaceuticals Inc 517,700 2,268,000 0.14%
34 ONCOMED PHARMACEUTICALS INC COM 190,000 2,339,000 0.14%
35 PROTEOSTASIS THERAPEUTICS IN COM 200,000 2,426,000 0.15%
36 COHERUS BIOSCIENCES INC COM 145,000 2,449,000 0.15%
37 ATRICURE INC 180,000 2,543,000 0.16%
38 TETRAPHASE PHARMACEUTICALS INC COM 600,000 2,580,000 0.16%
39 CIDARA THERAPEUTICS INC 264,000 2,722,000 0.17%
40 SYROS PHARMACEUTICALS INC 150,000 2,723,000 0.17%
41 GLOBAL BLOOD THERAPEUTICS INCORPORATED 165,000 2,737,000 0.17%
42 EPIZYME INC COM 275,000 2,816,000 0.17%
43 NATUS MEDICAL INC. 75,000 2,835,000 0.17%
44 GALAPAGOS NV 52,000 2,884,000 0.18%
45 VERTEX PHARMACEUTICALS INC 34,600 2,976,000 0.18%
46 REPLIGEN CORP COM 110,000 3,010,000 0.18%
47 CEMPRA INC 184,900 3,049,000 0.19%
48 INCYTE CORP 40,000 3,199,000 0.20%
49 TG THERAPEUTICS INC COM 537,600 3,258,000 0.20%
50 VOYAGER THERAPEUTICS INC 300,000 3,297,000 0.20%
Page 1 of 3

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001442891-16-000014, filed 2016.08.15).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.